Search

everythinglearnresearchcommunity

for

Search:↓

The combination of specific chemicals improves hair density in women.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Male cells need DHT to respond to testosterone, while female cells do not.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

TNF-alpha inhibitors can cause various immune-related skin issues.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Some drugs used to treat inflammation may cause hair loss.

Dupilumab for skin problems might reactivate hair loss in some patients.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Alstonia boonei phytochemicals show promise as alternative treatments for BPH with fewer side effects than current drugs.

Finasteride does not negatively affect male reproductive function.

Rats had lasting erectile problems after stopping a certain medication.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

No link found between specific genes and female pattern hair loss.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.